A case of diffuse midline glioma with histone H3 K27M mutation mimicking long segmental myelitis

A case of diffuse midline glioma with histone H3 K27M mutation mimicking long segmental myelitis

Diffuse midline glioma with H3 K27M mutation is a new tumor entity from 2016 which is highly aggressive and classified as a WHO Grade IV tumor regardless of histopathologic features. We report a case of a 40-year-old male with diffuse midline glioma with pathology confirmation of histone H3 K27M mut...

Full description

Bibliographic Details
Main Authors:	Hsin-Pin Lin, Cuiping Zhao, Vyas Viswanathan, Anthony T. Yachnis, James Wymer
Format:	Article
Language:	English
Published:	Elsevier 2021-03-01
Series:	Interdisciplinary Neurosurgery
Subjects:	Diffuse midline glioma H3 K27M mutation Myelitis Lower motor neuron syndrome Glioma Astrocytoma
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214751920305661

Similar Items

Tumor-Associated Microenvironment of Adult Gliomas: A Review
by: Vincenzo Di Nunno, et al.
Published: (2022-07-01)

A longitudinally extensive H3 K27M-mutant diffuse midline glioma in an elderly patient clinically mimicking central nervous system inflammation: a case report
by: Kristof Babarczy, et al.
Published: (2021-01-01)

MRI comparative study of diffuse midline glioma, H3 K27-altered and glioma in the midline without H3 K27-altered
by: Ji-ping Zhao, et al.
Published: (2022-12-01)

Diffuse Midline Gliomas: Challenges and New Strategies in a Changing Clinical Landscape
by: Umberto Tosi, et al.
Published: (2024-01-01)

Differences in the MRI Signature and ADC Values of Diffuse Midline Gliomas with H3 K27M Mutation Compared to Midline Glioblastomas
by: Peter Raab, et al.
Published: (2022-03-01)

Extra-neural metastases in pediatric diffuse midline gliomas, H3 K27-altered: presentation of two cases and literature review
by: Lucia De Martino, et al.
Published: (2023-07-01)

A curious case of T2-FLAIR mismatch in H3K27M mutant glioma
by: William L. Valentino, MD, MS, et al.
Published: (2022-09-01)

Histone H3 K27M-mediated regulation of cancer cell stemness and differentiation in diffuse midline glioma
by: Monika Sharma, et al.
Published: (2023-10-01)

Spinal Cord Diffuse Midline Glioma With Histone H3 K27M Mutation in a Pediatric Patient
by: Ran Cheng, et al.
Published: (2021-06-01)

Pediatric Diffuse Midline Gliomas H3 K27M-Mutant and Non-Histone Mutant Midline High-Grade Gliomas in Neurofibromatosis Type 1 in Comparison With Non-Syndromic Children: A Single-Center Pilot Study
by: Federica Garibotto, et al.
Published: (2020-06-01)

Diffuse midline glioma-H3K27M mutant. A novel entity with a defining and specific IHC marker
by: Prachi Agarwal, et al.
Published: (2021-01-01)

Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma
by: Tina Y. Huang, et al.
Published: (2017-04-01)

Histone-Mutant Glioma: Molecular Mechanisms, Preclinical Models, and Implications for Therapy
by: Maya S. Graham, et al.
Published: (2020-09-01)

New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of H3K27M-Mutant Diffuse Midline Glioma
by: Davis P. Argersinger, et al.
Published: (2021-10-01)

Flank Pain as a First Symptom of a Diffuse Midline Glioma
by: Burc Bassa, et al.
Published: (2023-01-01)

Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
by: Erik R. Peterson, et al.
Published: (2024-04-01)

A rare case of H3K27-altered diffuse midline glioma with multiple osseous and spinal metastases at the time of diagnosis
by: A. Kaywan Aftahy, et al.
Published: (2023-02-01)

Imaging findings of diffuse midline glioma with H3K27M mutation in the dorsal medulla oblongata: A rare case report
by: MingKang Shan, et al.
Published: (2023-12-01)

Current knowledge on the immune microenvironment and emerging immunotherapies in diffuse midline glioma
by: Gabrielle Price, et al.
Published: (2021-07-01)

The promise of metabolic imaging in diffuse midline glioma
by: Samantha Lovibond, et al.
Published: (2023-05-01)

Clinical Features and Molecular Markers on Diffuse Midline Gliomas With H3K27M Mutations: A 43 Cases Retrospective Cohort Study
by: Yuan Wang, et al.
Published: (2021-02-01)

Therapeutic avenues for targeting treatment challenges of diffuse midline gliomas
by: Aleeha Noon, et al.
Published: (2023-06-01)

Identification of Radiomic Signatures in Brain MRI Sequences T1 and T2 That Differentiate Tumor Regions of Midline Gliomas with H3.3K27M Mutation
by: Maria-Fatima Chilaca-Rosas, et al.
Published: (2023-08-01)

Case Report: Five Adult Cases of H3K27-Altered Diffuse Midline Glioma in the Spinal Cord
by: Quanquan Gu, et al.
Published: (2021-12-01)

Deep Learning for the Prediction of the Survival of Midline Diffuse Glioma with an H3K27M Alteration
by: Bowen Huang, et al.
Published: (2023-10-01)

VRK3 depletion induces cell cycle arrest and metabolic reprogramming of pontine diffuse midline glioma - H3K27 altered cells
by: Virginie Menez, et al.
Published: (2023-10-01)

Glucosylceramide Synthase Inhibitors Induce Ceramide Accumulation and Sensitize H3K27 Mutant Diffuse Midline Glioma to Irradiation
by: Khalifa El Malki, et al.
Published: (2023-06-01)

Interdisciplinary care of children with diffuse midline glioma
by: Christina Coleman, et al.
Published: (2023-01-01)

Exploiting Gangliosides for the Therapy of Ewing’s Sarcoma and H3K27M-Mutant Diffuse Midline Glioma
by: Arthur Wingerter, et al.
Published: (2021-01-01)

Deep learning‐based prediction of H3K27M alteration in diffuse midline gliomas based on whole‐brain MRI
by: Bowen Huang, et al.
Published: (2023-08-01)

Midline Gliomas: A Retrospective Study from a Cancer Center in the Middle East
by: Sarah Al Sharie, et al.
Published: (2023-09-01)

H3 K27-altered diffuse midline glioma in adults arising from atypical regions: Two case reports and literature review
by: Narushi Sugii, MD, PhD, et al.
Published: (2024-01-01)

H3K27me3 in Diffuse Midline Glioma and Epithelial Ovarian Cancer: Opposing Epigenetic Changes Leading to the Same Poor Outcomes
by: Charles A. Day, et al.
Published: (2022-10-01)

Therapeutic Targets in Diffuse Midline Gliomas—An Emerging Landscape
by: Elisha Hayden, et al.
Published: (2021-12-01)

Imaging characterization of an adult H3 K27M-altered diffuse midline glioma of the medulla oblongata with a confounding steroid response
by: Claudia Godi, MD, et al.
Published: (2023-03-01)

Decoding Diffuse Midline Gliomas: A Comprehensive Review of Pathogenesis, Diagnosis and Treatment
by: Sarah Al Sharie, et al.
Published: (2023-10-01)

Pediatric diffuse midline glioma H3K27- altered: A complex clinical and biological landscape behind a neatly defined tumor type
by: Stefano Gabriele Vallero, et al.
Published: (2023-01-01)

Driver Genetic Mutations in Spinal Cord Gliomas Direct the Degree of Functional Impairment in Tumor-Associated Spinal Cord Injury
by: Yoshitaka Nagashima, et al.
Published: (2021-09-01)

Exploring MRI Characteristics of Brain Diffuse Midline Gliomas With the H3 K27M Mutation Using Radiomics
by: Qian Li, et al.
Published: (2021-05-01)

Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma
by: Casper J. Pachocki, et al.
Published: (2022-11-01)